Both AChE and BChE are crucial in the treatment of neurodegenerative disorders such as Myasthenia gravis, Alzheimer and Parkinson’s disease, since generally all drugs in use act by inhibiting AChE and BChE activity6,8. Here, ACHE is linked to myasthenia gravis.